The HMGN5 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of HMGN5 in a human lung adenocarcinoma model. This genetically heterogeneous pool was generated by CRISPR/Cas9-mediated disruption of the HMGN5 gene within the NCI-H1975 host cell line, providing a versatile tool for investigating gene function without clonal selection. The polyclonal format maintains population-level diversity, enabling robust assessment of HMGN5-dependent phenotypes in a relevant cancer background.
The host cell line, NCI-H1975, is derived from a female non-smoker with lung adenocarcinoma and harbors endogenous EGFR L858R and T790M mutations. These activating and resistance-conferring mutations make NCI-H1975 a widely used model for studying EGFR-mutant non-small cell lung cancer (NSCLC), oncogenic signaling, and mechanisms of drug resistance, particularly to tyrosine kinase inhibitors. The epithelial morphology and tumorigenic properties of NCI-H1975 facilitate both in vitro and in vivo assays relevant to lung cancer biology.
HMGN5 is a chromatin architectural protein that destabilizes nucleosomes and facilitates transcription factor access, thereby regulating gene expression programs governing cell cycle progression, DNA repair, and differentiation. Upstream regulators such as c-Myc and EGF/EGFR signaling positively modulate HMGN5 expression, while microRNAs miR-124 and miR-28-5p negatively regulate it. HMGN5 functions in key pathways including Wnt/??-catenin and TGF-?? signaling, where it promotes transcription of downstream targets such as cyclin D1, c-Myc, Bcl-2, and matrix metalloproteinases MMP2 and MMP9, while repressing tumor suppressors like p21 and E-cadherin. HMGN5 interacts with nucleosomes, histone H1, chromatin remodeling complexes, and transcriptional coactivators to orchestrate an open chromatin state that drives proliferation and survival.
In the EGFR-mutant NCI-H1975 context, HMGN5 knockout is particularly significant because EGFR signaling converges on many HMGN5-regulated pathways. Disruption of HMGN5 is anticipated to reduce expression of oncogenic drivers and increase tumor suppressors, impairing growth and metastatic potential. This model enables dissection of chromatin-mediated contributions to EGFR-driven oncogenesis and acquired drug resistance. Additionally, HMGN5??s role in epithelial-mesenchymal transition (EMT), through regulation of E-cadherin, vimentin, and Snail, makes this knockout a powerful tool for studying invasion and metastasis mechanisms in lung adenocarcinoma.
Representative research applications include investigating chromatin structure and transcriptional regulation in lung cancer, studying HMGN5 roles in EGFR-mutant progression and resistance, screening for synthetic lethality partners, and examining EMT mechanisms. Typical assays applied to these polyclonal knockout cells encompass western blotting, RT-qPCR, RNA-seq, ChIP-qPCR, immunofluorescence, flow cytometry for cell cycle and apoptosis, migration and invasion assays, drug sensitivity assays (MTT, colony formation), co-immunoprecipitation, and reporter assays. For further information, please contact Ascent Research.
